← Back
$CRNX All transactions

Crinetics Pharmaceuticals, Inc.

▼ SELL 10b5-1 Plan

$ Value

$189K

Shares

6,492

Price

$29

Filed

Aug 21

Insider

Name

Pizzuti Dana

Title

Chief Med and Dev Officer

CIK

0001948238

Roles

Officer

Transaction Details

Transaction Date

2025-08-20

Code

S

Table

Non-Derivative

Ownership

Direct

Equity Swap

No

Shares After

66,270

Footnotes

The sale reported in this Form 4 was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 21, 2025. | The common stock was sold by the Reporting Person in open market transactions on the transaction date, with a volume weighted average sales price of $29.18 per share. The range of sales prices on the transaction date was $28.94 to $29.47 per share. Detailed information on the exact number of shares can be obtained from the Issuer upon request. | Includes 529 shares acquired under the Issuer's Employee Stock Purchase Plan.

Filing Info

Accession No.

0001948238-25-000005

Form Type

4

Issuer CIK

0001658247

Pizzuti Dana's History

Date Ticker Type Value
2025-12-01 CRNX M $84K
2025-12-01 CRNX $225K
2025-12-01 CRNX M $0
2025-11-03 CRNX M $84K
2025-11-03 CRNX $209K
2025-11-03 CRNX $4K
2025-11-03 CRNX M $0
2025-10-01 CRNX M $84K
2025-10-01 CRNX $209K
2025-10-01 CRNX M $0

Other Insiders at CRNX (90d)

Insider Bought Sold Last
Knight Jeff E.
Chief Dev. & Operating Officer
$3.4M 2026-04-08